Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Outstanding (Diluted Average): 2021-2022

Historic Shares Outstanding (Diluted Average) for Candel Therapeutics (CADL) over the last 2 years, with Dec 2022 value amounting to $28.8 million.

  • Candel Therapeutics' Shares Outstanding (Diluted Average) rose 0.10% to $28.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 0.10%. This contributed to the annual value of $28.8 million for FY2022, which is 52.72% up from last year.
  • Per Candel Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $28.8 million for FY2022, which was up 52.72% from $18.9 million recorded in FY2021.
  • Candel Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $28.8 million for FY2022, and its period low was $18.9 million during FY2021.
  • Its 2-year average for Shares Outstanding (Diluted Average) is $23.8 million, with a median of $23.8 million in 2021.
  • Data for Candel Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY surged of 52.72% (in 2022) over the last 5 years.
  • Over the past 2 years, Candel Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $18.9 million in 2021, then soared by 52.72% to $28.8 million in 2022.